Department of Pharmacotherapeutics
Course of Medical and Dental Sciences
Teaching Staff
Name Position E-mail Tel Fax
Kazuhiro Tsukamoto, M.D. & Ph. D.
Professor +81-95-819-8573 +81-95-819-8575
Tatsuo Inamine, Ph.D
Assistant Professor +81-95-819-8575 +81-95-819-8575
  • Research into association studies on susceptibility genes for diseases, progression, drug effectiveness, adverse effects, and prognosis using genetic polymorphic markers
  • Research into DNA-based diagnostic methods for personalized medicine
  • Elucidation of pathological molecular mechanisms of cleft lip/cleft palate
Selected Publications
  1. Mochinaga K, Tsuchiya T, Nagasaki T, Arai J, Tominaga T, Yamasaki N, Matsumoto K, Miyazaki T, Nanashima A, Hayashi T, Tsukamoto K, Nagayasu T, High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non-small-cell lung cancer using 5-fluorouracil, Clin. Lung Cancer 15: 136-144 (2014)
  2. Ikeda T, Fukuda M, Nakamura Y, Kinoshita A, Senju H, Nakano H, Kitazaki T, Ogawara D, Taniguchi H, Motoshima K, Yamaguchi H, Nakatomi K, Shimada M, Nagashima S, Tsukamoto K, Kohno S, A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer, Cancer Chemother. Phrmacol. 74: 497-502 (2014)
  3. Urabe S, Isomoto H, Ishida T, Maeda K, Inamine T, Kondo S, Higuchi N, Sato K, Uehara R, Yajima H, Machida H, Chen CC, Fukuda Y, Takeshima F, Nakao K, Tsukamoto K, Genetic polymorphisms of IL-17F and TRAF3IP2 could be predictive factors of the long-term effect of infliximab against Crohn’s disease, Biomed. Res. Int. ID 416838, 1-12 (2015)
  4. Kasai T, Nakamura Y, Fukuda M, Kitazaki T, Nagashima S, Takatani H, Nakano H, Nakatomi K, Ikeda T, Yamaguchi H, Tsukamoto K, Oka M, Kohno S, A phase II study of S-1 for previously untreated elderly patients with advanced non-small cell lung cancer, Chemotherapy 61: 93-98 (2015)
Research Paper List